Among the changes, the FDA is requiring boxed warnings for nearly 400 products, as well as patient-focused Medication Guides for prescription opioids and benzodiazepines.
Theranos is facing its latest crisis following its withdrawal of its request for emergency clearance of a Zika-virus blood test after federal regulators found that the company didn’t include proper patient safeguards in a study of the new test, The Wall Street Journal reported Tuesday, citing people familiar with the matter. "Theranos founder Elizabeth Holmes announced Aug. 1 a new blood-testing device called miniLab that she said was designed for use outside a clinical laboratory and could run accurate tests from a few drops of blood," The Journal wrote. "But during an inspection by the FDA earlier this month, regulators concluded that Theranos had collected some data supporting the accuracy of the Zika test without implementing a patient-safety protocol approved by an institutional review board." (The Wall Street Journal)
Members of participating plans will be able to receive 90-day supplies of their diabetes maintenance meds from more than 10,000 pharmacies – including Walgreens and at more than 1,200 independent retail pharmacies.
Consumers aren’t ready to let go of print coupons.
Jeff Jones, executive vice president, chief marketing officer at Target, is leaving the company.
Eight young moms in the Boston area are getting a new start in life after completing a pharmacy technician training program through a partnership with CVS Health and a Massachusetts nonprofit, according to the Boston Globe.
New research from Experian Marketing Services points to five strategies that brands and retailers should implement to boost marketing plan performance during the key holiday shopping season.
Fred's new CEO Mike Bloom pledged new initiatives will launch in the back half of 2016 that will help set the stage to combat growth headwinds.
Fred's draws from a strong executive team in naming the leaders that will carry the discount pharmacy retailer into the future.
DUBLIN, Ohio — Accoding to a report published Monday in The Columbus Dispatch, Cardinal Health has purchased TelePharm, a firm that offers secure Internet-based pharmacy services such as prescription approval. A Cardinal spokesman told The Dispatch that the company "will work with the TelePharm leadership team to identify opportunities to integrate the technology" with existing services Cardinal offers to pharmacies. (The Columbus Dispatch)